Skip to Main Content

Advertisement

Skip Nav Destination

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia

Blood Adv (2018) 2 (3): 224–234.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement